Last update 20 Sep 2025

DC50292A

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DC50292A
Target-
Action-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
Malignant Solid NeoplasmMethylthioadenosine phosphorylase deletion cancerAdvanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Beijing Double-Crane Runchuang Technology Co., Ltd.
Active Organization
Beijing Double-Crane Runchuang Technology Co., Ltd.China Resources Double-Crane Pharmaceutical Co., Ltd.China Resources Double-Crane Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DC50292A
NCT07071090
/ RecruitingPhase 1
An Open-Label Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
100 Clinical Results associated with DC50292A
Login to view more data
100 Translational Medicine associated with DC50292A
Login to view more data
100 Patents (Medical) associated with DC50292A
Login to view more data
100 Deals associated with DC50292A
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malignant Solid NeoplasmPhase 1
China
China Resources Double-Crane Pharmaceutical Co., Ltd.China Resources Double-Crane Pharmaceutical Co., Ltd.
30 Jun 2025
Methylthioadenosine phosphorylase deletion cancerPhase 1
China
China Resources Double-Crane Pharmaceutical Co., Ltd.China Resources Double-Crane Pharmaceutical Co., Ltd.
30 Jun 2025
Advanced Malignant Solid NeoplasmIND Approval
United States
Beijing Double-Crane Runchuang Technology Co., Ltd.
30 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free